Here’s Why Cerecor (CERC) Stock is up 16% Today

 

Shares of Cerecor (CERC) stock jumped 48% in early pre-market trading Friday, rising as high as $6.67 after the company announced it received a U.S. patent for CERC-301. Cerecor is a bio-pharmaceutical company largely focused on treatments of rare pediatric and neurology diseases.

Cerecor stock is currently trading at $5.25 as of 9:52 AM on Friday, Feb 15, a gain 16.58% from the previous closing price of $4.50.

CERC stock has traded between $5.06 and $5.40 so far today. Volume today is above average. So far 167,744 shares have traded compared to average volume of 80,702 shares.

Get More Analysis and Trade Ideas on Cerecor (CERC) Stock

CERC-301 is an oral treatment in development for treating neurogenic orthostatic hypotension, a rare disorder creating low blood pressure upon standing, in people with neurodegenerative diseases such as Parkinson’s Disease.

The patent, along with its foreign counterpart applications, are co-owned with Merck & Co. (MRK).

Analyst Insight

Stock Score Report, InvestorsObserver’s proprietary scoring system gives CERC stock a score of 80 out of a possible 100. That score is based on three component scores. A fundamental score of 71, a long-term technical score of 79 and a short-term technical score of 90.

CERC stock scores highly in all categories, signaling strength in the stock. Cerecor stock holds an analyst average recommendation of Strong Buy, with a median target price of $8.00, which is 53.5% higher than the stocks current trading price.

Our proprietary system combines short and long-term technical factors, Wall Street’s opinion, and other fundamental factors into an overall score that measures a stock’s suitability for investment.

Get More Analysis and Trade Ideas on Cerecor (CERC) Stock

Meanwhile, the major indices are rallying. The S&P 500 is up 0.71% to 2,765.28. The Dow Jones Industrial Average is up 0.67% to 25,715.14. The NASDAQ has gained 0.3% to 7,449.10.

Symbols: CERC MRK

You May Also Like